|January 17, 2014|
|12:00 EDT||NUS||Nu Skin falls 8.5%|
Nu Skin is down 8.5%, or $7.17, to $77.63
News For NUS From The Last 14 Days
Check below for free stories on NUS the last two weeks.
|August 18, 2014|
|09:54 EDT||NUS||Nu Skin mentioned cautiously by Bronte Capital|
|August 13, 2014|
|06:39 EDT||NUS||Nu Skin volatility flat as shares near15-month low |
Nu Skin August call option implied volatility is at 45, September and December is at 44; compared to its 26-week average of 47 according to Track Data, suggesting decreasing price movement.
|August 7, 2014|
|10:00 EDT||NUS||On The Fly: Analyst Downgrade Summary|
Subscribe for More Information
|06:08 EDT||NUS||Nu Skin orice target lowered to $70 from $110 at Deutsche Bank|
Deutsche Bank lowered its price target for Nu Skin shares to $70 saying the regulatory overhang "continue to wreak havoc on the company’s important China business." The firm, however, says comparisons ease next year and that inventory can be worked down or written off. Deutsche keeps a Buy rating on Nu Skin following yesterday's Q2 results. Note the stock was downgraded this morning at JPMorgan to Neutral.
|05:48 EDT||NUS||Nu Skin downgraded to Neutral from Overweight at JPMorgan|
JPMorgan downgraded Nu Skin to Neutral saying the underlying business is weaker than it expected with little visibility following the company's Q2 results. The firm cut its price target for shares in half to $50 from $100. Nu Skin closed yesterday down $11.40 to $46.52 after reporting Q2 results.